醋酸戈舍瑞林

CAS号
65807-02-5 ;145781-92-6
CCD编号
CCD00250275
分子式
C59 H84 N18 O14 . C2 H4 O2
分子量
1329.48

基本信息

产品名称: 醋酸戈舍瑞林
CAS: 65807-02-5 ;145781-92-6
中文同义词: 醋酸戈舍瑞林
英文同义词: (D-SER(TBU)6,AZAGLY10)-LHRH ACETATE SALT ; ZOLADEX ACETATE ; DECAPEPTIDE I ACETATE ; GOSERELINA ACETATE ; GLP-HIS-TRP-SER-TYR-SER(TBU)-LEU-ARG-PRO-AZAGLY-NH2 ; (D-SER(TBU)6,AZAGLY10)-LHRH ACETATE ; GLP-HIS-TRP-SER-TYR-SER(TBU)-LEU-ARG-PRO-AZAGLY-NH2 ACETATE ; GOSERELINUM ACETATE ; GOSERELIN ; PYR-HIS-TRP-SER-TYR-D-SER(TBU)-LEU-ARG-PRO-AZAGLY-NH2 ACETATE SALT ; GOSERELIN ACETATE ; GOSERELINE ACETATE ; GOSERELIN ACETATE SALT ; PYR-HIS-TRP-SER-TYR-D-SER(TBU)-LEU-ARG-PRO-AZAGLY-NH(2) ; ICI 118630 ACETATE
MDL号: MFCD01747329
氢键受体数量: 32
氢键供体数量: 18
Smile: CC(C)C[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]c4c3cccc4)NC(=O)[C@H](Cc5c[nH]cn5)NC(=O)[C@@H]6CCC(=O)N6.CC(=O)O
InChi: InChI=1S/C59H84N18O14.C2H4O2/c1-31(2)22-40(49(82)68-39(12-8-20-64-57(60)61)56(89)77-21-9-13-46(77)55(88)75-76-58(62)90)69-54(87)45(29-91-59(3,4)5)74-50(83)41(23-32-14-16-35(79)17-15-32)70-53(86)44(28-78)73-51(84)42(24-33-26-65-37-11-7-6-10-36(33)37)71-52(85)43(25-34-27-63-30-66-34)72-48(81)38-18-19-47(80)67-38;1-2(3)4/h6-7,10-11,14-17,26-27,30-31,38-46,65,78-79H,8-9,12-13,18-25,28-29H2,1-5H3,(H,63,66)(H,67,80)(H,68,82)(H,69,87)(H,70,86)(H,71,85)(H,72,81)(H,73,84)(H,74,83)(H,75,88)(H4,60,61,64)(H3,62,76,90);1H3,(H,3,4)/t38-,39-,40-,41-,42-,43-,44-,45+,46-;/m0./s1
InChiKey: InChIKey=IKDXDQDKCZPQSZ-JHYYTBFNSA-N

性质

注解: BIOCHEM/PHYSIOL ACTIONS: GOSERELIN IS A SYNTHETIC ANALOG OF LHRH (LEUTINIZING HORMONE RELEASING HORMONE). GOSERELIN IS A LHRH AGONIST IT IS USED IN PROSTATE CANCER AND BREAST CANCER THERAPIES AND ALSO IN THE TREATMENT OF ENDOMETRIOSIS
GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA
OTHER NOTES: SALES RESTRICTIONS MAY APPLY

安全信息

WGK德国: 3

* If the product has intellectual property rights, a license granted is must or contact us.